Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Working Capital Changes (2016 - 2025)

OptimizeRx (OPRX) has disclosed Other Working Capital Changes for 16 consecutive years, with $90000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 106.31% to $90000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2025, up 101.48% year-over-year, with the annual reading at $12000.0 for FY2025, 101.48% up from the prior year.
  • Other Working Capital Changes hit $90000.0 in Q4 2025 for OptimizeRx, up from -$1.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.7 million in Q1 2023 to a low of -$1.4 million in Q2 2023.
  • Historically, Other Working Capital Changes has averaged -$117145.4 across 5 years, with a median of -$82500.0 in 2023.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 9713.88% in 2022 and later soared 1890.16% in 2023.
  • Year by year, Other Working Capital Changes stood at $1.1 million in 2021, then crashed by 140.63% to -$451618.0 in 2022, then skyrocketed by 79.85% to -$91000.0 in 2023, then plummeted by 1467.03% to -$1.4 million in 2024, then soared by 106.31% to $90000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for OPRX at $90000.0 in Q4 2025, -$1.0 million in Q3 2025, and $1.0 million in Q2 2025.